Jiangxi Fushine Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is BETA-METHYL VINYL PHOSPHATE, with a corresponding US DMF Number 28771.
Remarkably, this DMF maintains an Active status since its submission on October 21, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 20, 2019, and payment made on May 13, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II